Webinar: Using Social Determinants of Health to Understand the Impact of COVID-19
December 15, 2020 3:00 - 4:00pm ET Webcast
In recent years, real-world data’s role in bringing therapies to market has expanded, not just to maximize access for patients when treatments become available, but also increasingly as an input to the clinical development process. Furthermore, COVID-19 has created an immediate urgency to answer questions on safety, efficacy, and access sooner, and the need for sharing these findings and lessons across the industry in real-time. As real-world data has transitioned from a nice-to-have to a must-have, it is more important than ever to understand the full capabilities of linking to and effectively incorporating real-world data in clinical studies.
Join us in this panel discussion moderated by clinical trials expert, Craig Lipset and featuring key opinion leaders from Janssen Pharmaceuticals, AbbVie, and PAREXEL to answer critical questions such as:
- What are examples of successful applications of real-world data in clinical trials? And, what role has COVID-19 played in reshaping this?
- What are the best practices for incorporating real-world data into clinical trials, including addressing privacy and patient consent?
- How can solutions and innovations in the trial space improve the utilization and adoption of real-world data?
Founder and Advisor
Clinical Innovation Partners
Chris Boone, PhD, FACHE, FHIMSS
VP, Global Head of Health Economics & Outcomes Research
Sean Khozin, MD, MPH
Global Head of Data Science Innovation
Chief Data Officer
Register for Webinar
Register for this webinar through Zoom by clicking the link below.